Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Avastin off-licence

- PMLiVE

Omega buys pharmacy to understand customers

Will turn Warman-Freed in North London into ‘learning pharmacy’

Bayer symbol

Bayer wins GIST approval for Stivarga in EU

Cancer drug can be used after Pfizer’s Sutent and Novartis’ Glivec

UK minister: ‘End animal testing’

LibDem MP Norman Baker says there is an economic case for finding an alternative

- PMLiVE

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

UK flag

Pharma firms open up drug libraries to UK researchers

AZ, GSK, Janssen, Lilly, Pfizer, Takeda and UCB partner with Medical Research Council

UK flag

Antimicrobial resistance priority for new UK science minister

Greg Clark announces collaboration led by Medical Research Council

- PMLiVE

Bayer names head of US litigation

Malini Moorthy joins from Pfizer

- PMLiVE

UK appoints Greg Clark as new science minister

Cabinet reshuffle also sees George Freeman made minister for life sciences

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

France flag

Pharma criticises France’s backing for off-label Avastin use

EFPIA weighs in on proposal to move wet AMD patients to the drug as a cheaper alternative

- PMLiVE

France wants Avastin used in place of Lucentis

Government calls for off-label use of Roche drug in order to reduce spend on eye therapy

UK flag

Pharma industry backs UK antibiotics plan

GSK and ABPI back David Cameron’s call for global action on antimicrobial resistance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links